Can Genomics Solve Rare Diseases? - Top-Institutions - MDSpire

Can Genomics Solve Rare Diseases?

Experts discuss why half of rare disease cases remain unsolved and how advanced genomics could improve diagnostic yield

  • March 24, 2026

  • 10 min

Share

Top Institutions in Internal Medicine

Brief introduction explaining scope and methodology.

  • #1

    Broad Institute of MIT and Harvard
    Broad Institute of MIT and Harvard

    Cambridge, MA

    Key Differentiators

    • Genomic Medicine
    • Rare Disease Research
    • Bioinformatics

  • #2

    National Institutes of Health (NIH) - Undiagnosed Diseases Network
    National Institutes of Health (NIH) - Undiagnosed Diseases Network

    Bethesda, MD

    Key Differentiators

    • Rare Disease Diagnostics
    • Genomic Medicine
    • Clinical Genetics

  • #3

    Children’s Hospital of Philadelphia (CHOP) - Center for Applied Genomics
    Children’s Hospital of Philadelphia (CHOP) - Center for Applied Genomics

    Philadelphia, PA

    Key Differentiators

    • Pediatric Genomics
    • Rare Disease Diagnostics
    • Clinical Genomics

  • #4

    Stanford University School of Medicine - Center for Genomics and Personalized Medicine
    Stanford University School of Medicine - Center for Genomics and Personalized Medicine

    Stanford, CA

    Key Differentiators

    • Genomic Medicine
    • Rare Disease Research
    • Personalized Medicine

  • #5

    University of Washington - Center for Mendelian Genomics
    University of Washington - Center for Mendelian Genomics

    Seattle, WA

    Key Differentiators

    • Mendelian Genetics
    • Rare Disease Genomics
    • Genomic Sequencing

Original Source(s)

Can Genomics Solve Rare Diseases?

  • March 24, 2026

Related Content

SSc May Be Linked to Subtle Cognitive Changes

Cross-sectional study finds domain-specific differences and higher anxiety without global impairment.

Semaglutide Use Linked to Erythromelalgia Remission

Case details diagnostic workup and rapid symptom resolution following GLP-1 receptor agonist initiation.

Valved Holding Chambers in Young Children With Acute Wheezing: A Randomized Clinical Trial